Malfunctions in the process of CSR may result in the development of primary immunodeficiency diseases (PID), such as HIGM, which is attributed to mutations in BCR or coreceptor signaling components (such as CD19 or CD40). This evidence concerns the gene CD19 and hyper-IgM syndrome type 1.